Our groundbreaking AI algorithms have been designed to deliver lower, more comfortable air pressures. This leads to an improvement in comfort and adherence on conventional CPAP machines. Building on cMAP™’s proprietary technology, we are also creating the groundwork to build the next generation of battery-enabled, wearable CPAPs.
cMAP™ is being developed based on tens of thousands of apneas collected from in-home patient’s CPAP machines. cMAP™ has been validated in a first-in-human trial on current CPAPs in a double-blinded sleep lab study at the QEII hospital in Halifax, Canada.
Learn about the benefits that increased adherence can have for your companyContact Us